秋水仙碱、苯溴马隆胶囊联合治疗痛风性关节炎非急性发作期
A Clinical Study of Combined Therapy of Colchicine and Benzbromarone Capsules in the Treatment of Gouty Arthritis at Non-Acute Episode Stage
-
摘要: 目的 探析秋水仙碱、苯溴马隆胶囊联合治疗痛风性关节炎非急性发作期的临床价值.方法 收集2015年12月至2017年2月核工业四一六医院收治的60例痛风性关节炎非急性发作期患者, 随机分为联合组和对照组, 各30例.对照组给予苯溴马隆胶囊, 联合组给予秋水仙碱+苯溴马隆胶囊, 对比2组患者治疗前后实验室指标[血尿酸、血沉 (ESR) 、C反应蛋白 (CRP) 、丙氨酸转氨酶 (ALT) 、肾小球滤过率 (GFR) ]、疼痛症状及生活质量的变化情况, 统计急性痛风性关节炎的发作次数及药物不良反应的发生率.结果 治疗前2组患者实验室相关指标、临床症状及生活质量对比差异无统计学意义 (P>0.05) ;疗程结束后, 2组患者ALT、GFR水平未见明显波动, 但血尿酸、ESR、CRP、疼痛症状及生活质量均得到改善, 联合组改善程度较对照组优;同时, 治疗期间联合组急性痛风性关节炎的发作次数亦较对照组少, 上述指标组间对比差异具有统计学意义 (P<0.05) , 联合组不良反应总发生率为30.00%, 与对照组的26.67%行组间比较差异无统计学意义 (χ2=0.180, P=0.857) .结论 秋水仙碱、苯溴马隆胶囊联合治疗痛风性关节炎非急性发作期安全性与单用苯溴马隆胶囊无异, 且疗效优于单一使用苯溴马隆.
-
关键词:
- 秋水仙碱 /
- 苯溴马隆胶囊 /
- 痛风性关节炎非急性发作期
Abstract: Objective To explore and analyze the clinical values of combined therapy of colchicine and benzbromalone capsules in the treatment of gouty arthritis of non-acute episode. Methods From December 2015 to February 2017, 60 patients with gouty arthritis who were not in acute attack were randomly divided into the combined group and the control group, with 30 cases in each group. The control group was given benzbromarone capsules and the combined group was given colchicine combined with benzbromarone capsules. The changes of laboratory indexes [blood uric acid, erythrocyte sedimentation rate (ESR) , C reactive protein (CRP) , alanine aminotransferase (ALT) , glomerular filtration rate (GFR) ], and clinical symptoms (pain, lesion joint limitation, fever, redness and tenderness) were measured and compared in the two groups before and after the treatment. The daily living ability scale (SF-36) was used to evaluate the quality of daily life before and after the treatment, and the incidence rate of drug adverse reactions during the treatment was also counted. Results No significant differences were found in the laboratory related indexes, clinical symptoms and quality of life before the treatment between the two groups (P>0.05) . After the treatment, the levels of ALT and GFR were not significantly fluctuated in the two groups, but the levels of blood uric acid, ESR, CRP, pain symptoms and quality of life were improved, and the increasing degree in the combined group was more significant than that of the control group. and the number of episodes of acute gouty arthritis in the combined group was also lower than that in the control group, and the difference between the above indexes was statistically significant (P<0.05) . The total incidence rate of adverse reactions was 30% in the combined group, which was not significantly different from that in the control group with 26.67% (χ2 = 0.180, P = 0.857) . Conclusions The use of colchicine combined with benzbromalone capsules is as the safe as the single use of benzbromalone capsules and the effect of the former one is better than that of the latter one in the treatment of gouty arthritis at non-acute episode stage. -
[1]周丽丽.吲哚美辛加如意金黄散外敷治疗急性痛风性关节炎的疗效观察[J].重庆医学, 2015, 44 (7) :969-970. [2]潘承.排酸保肾方治疗高尿酸血症及急性痛风性关节炎临床研究[J].四川中医, 2016, 34 (6) :100-102. [3]高莹, 张治然, 汤志宏, 等.苯溴马隆联合痛风定胶囊治疗痛风性关节炎的疗效观察[J].临床军医杂志, 2015, 43 (10) :1060-1062. [4]李建军, 王为.萆薢黄柏饮与秋水仙碱治疗痛风的疗效对比观察[J].中国中医急症, 2015, 24 (2) :317-318. [5]中华医学会风湿病学分会.原发性痛风诊断和治疗指南[J].中华风湿病学杂志, 2011, 15 (6) :410-413. [6]袁艳平, 李长贵.急性痛风性关节炎的规范化治疗[J].医学综述, 2014, 20 (21) :3902-3905. [7]丁小力, 戈朝晖, 刘云宏, 等.肩关节内玻璃酸钠注射联合口服扶他林、乙哌立松治疗早期冻结肩的临床效果[J].宁夏医科大学学报, 2015, 37 (7) :845-847. [8]刘晓波, 陈丽燕, 李爱民.探讨以SF-36量表为主要内容的生存质量评估在中医治疗类风湿关节炎疗效评价体系中的重要性[J].中国中医药信息杂志, 2016, 23 (10) :10-12. [9]孟伟, 周陆凝, 张真瑞, 等.自拟土丹汤治疗急性痛风性关节炎及高尿酸血症疗效观察[J].四川中医, 2016, 34 (5) :110-113. [10]袁艳平, 李长贵.痛风性关节炎患者血清白细胞介素-1β、肿瘤坏死因子-α、环氧化酶-2水平的动态变化研究[J].中华风湿病学杂志, 2013, 17 (12) :818-822. [11]梁慧英, 廖琳, 何善智, 等.中西医结合分期治疗慢性期痛风性关节炎30例临床观察[J].中医杂志, 2015, 56 (2) :136-139. [12]金晓畅, 郝志民, 于清欣, 等.六味痛风饮治疗痛风性关节炎60例临床观察[J].山东中医药大学学报, 2015, 39 (3) :235-237. [13]顾雪, 张莉, 孟梅霞, 等.黄葵胶囊联合苯溴马隆治疗尿酸性肾病临床研究[J].国际中医中药杂志, 2016, 38 (9) :804-807. [13]李爱平, 王振青.秋水仙碱联合别嘌醇治疗急性痛风性关节炎疗效分析[J].河北医学, 2014, 20 (11) :1912-1913. [14]刘颖, 李志琛, 陈建斌, 等.小剂量秋水仙碱联合糖皮质激素治疗急性痛风性关节炎的疗效观察[J].解放军医学杂志, 2015, 40 (8) :652-655. [15]崔炎, 王平, 张榜, 等.急性痛风性关节炎与血尿酸及尿酸盐结晶的关系[J].中国中西医结合外科杂志, 2014, 20 (5) :501-503. [16]李育红, 张清安, 万文军, 等.秋水仙碱两种给药方案治疗痛风急性发作的临床观察[J].中国药房, 2013, 24 (28) :2642-2644. [17]杨彦龙, 李小琴, 史静, 等.小剂量秋水仙碱联合得宝松治疗急性痛风性关节炎的疗效分析[J].检验医学与临床, 2016, 13 (15) :2103-2105. [18]张杰, 邓文郁, 陈芍, 等.重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白联合甲氨蝶呤治疗类风湿关节炎50例临床观察[J].实用医院临床杂志, 2015, 12 (5) :180-182, 183. [19]石玲玲, 郑佳鹏, 郭志民, 等.关节镜下碱性灌洗液治疗痛风性关节炎的实验研究[J].西部医学, 2015, 27 (8) :1138-1140. [20]梁华玉, 王育琴.苯溴马隆肝毒性机制的研究进展[J].药物不良反应杂志, 2016, 18 (4) :286-289. [21]柯渠青, 邱晓堂, 黄妮, 等.小剂量秋水仙碱联合依托考昔治疗急性痛风性关节炎的临床观察[J].中国医药导报, 2016, 13 (33) :129-132.
点击查看大图
计量
- 文章访问数: 1646
- HTML全文浏览量: 527
- PDF下载量: 108
- 被引次数: 0